MeiraGTx Holdings PLC (MGTX)

Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell

$5.97

Buy

$5.98

arrow-down$-0.12 (-1.97%)

Prices updated at 19 Nov 2024, 18:18 EST
| Prices minimum 15 mins delay
|
Prices in USD
MeiraGTx Holdings PLC is a clinical stage gene therapy company. Its pipeline products include AAV-CNGB3, AAV-CNGA3. AAV-UPF1, West AMD, Dry AMD, and others. Geographically, the company generates a majority of its revenue from the United Kingdom.
NASDAQ
arrow-up0.7%
NASDAQ
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
$6.29 - $5.87
$7.60 - $3.85
-
328.80m
-
-
62,615
4.97
238,968.18
1.25
63.60m
KYG596651029
-1.20
-
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2024 Morningstar. All rights reserved.